Laboratorios Farmaceuticos Rovi, S.A. (41L.F)

82,25 -1,60 (-1,91%) Börsenschluss: 08:06AM CEST

Laboratorios Farmaceuticos Rovi, S.A.

Calle José Isbert, 2
Pozuelo de Alarcón
Madrid 28223
Spain
34 91 021 30 00
https://www.rovi.es

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 1.925

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Ivan Lopez-Belmonte Encina	Second Deputy Chairman & GM of Commercial and Development	472k	N/A	N/A
Mr. Javier Lopez-Belmonte Encina	First Deputy Chairman, GM of Industrial Operations & CFO	474k	N/A	N/A
Mr. Juan Lopez-Belmonte Encina	Chairman & CEO	1,15M	N/A	N/A
Marta Campos Martínez	Head of Investor Relations	N/A	N/A	N/A
Ms. Mercedes Benítez del Castillo Sánchez	Legal Department Manager	N/A	N/A	N/A
Ms. Beatriz Ávila Alcalde	Sales Manager	N/A	N/A	N/A
Ms. Rosario Perucha Pérez	Marketing Manager	N/A	N/A	N/A
Mr. Francisco Javier Angulo García	Human Resources Manager	N/A	N/A	N/A
Mr. Gabriel Nunez Fernandez	Secretary	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.

Corporate Governance

Laboratorios Farmaceuticos Rovi, S.A.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 4. Die grundlegenden Scores sind Audit: 8, Vorstand: 7, Shareholderrechte: 6, Kompensation: 1.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.